X
Upload your Marketing & Sales content on your company Virtual Booth, click HERE.
https://www.prnewswire.com/news-releases/freya-pharma-solutions-announces-advice-from-the-fda-on-its-us-clinical-development-program-of-lybrido-for-the-treatment-of-female-sexual-interestarousal-disorder-301819298.html
https://www.prnewswire.com/news-releases/freya-pharma-solutions-appoints-christa-van-kan-as-director-clinical-operations-governing-the-companys-upcoming-confirmatory-clinical-development-program-using-lybrido-against-fsiad-301765654.html
https://www.prnewswire.com/news-releases/freya-pharma-solutions-innovative-compound-lybrido-for-the-treatment-of-female-sexual-dysfunction-well-received-at-european-society-for-sexual-medicine-congress-301752964.html
https://www.prnewswire.com/news-releases/freya-pharma-solutions-extends-its-scientific-advisory-board-with-usa-based-international-leading-experts-in-the-field-of-female-sexual-disorders-301743897.html
https://www.prnewswire.com/news-releases/freya-pharma-solutions-appoints-nicole-hijnen-as-president-of-the-board-overseeing-the-companys-upcoming-clinical-development-program-with-lybrido-against-fsiad-301737293.html
https://www.prnewswire.com/news-releases/freya-pharma-solutions-aletta-pivotal-trial-well-received-at-issmsmsna-scientific-meeting-301668821.html
https://www.pharmaceutical-technology.com/news/female-sexual-interest-drug-reaches-tipping-point-with-phase-iii-plans/
https://www.prnewswire.com/news-releases/freya-pharma-solutions-receives-early-ema-scientific-advice-on-its-upcoming-phase-3-clinical-trial-to-confirm-efficacy-of-lybrido-in-women-suffering-from-fsiad-301635252.html
https://www.prnewswire.com/news-releases/freya-pharma-solutions-announced-further-strengthening-of-its-ip-position-for-improved-treatment-for-women-suffering-from-fsiad-301611898.html
https://www.prnewswire.com/news-releases/freya-pharma-solutions-announced-its-application-for-ema-scientific-advice-on-its-phase-3-clinical-trial-to-confirm-efficacy-of-lybrido-in-women-suffering-from-fsiad-301578076.html
Market Place
Share 
